Advertisement

Using an algorithm to assess the rate and trend over time of inappropriate proton pump inhibitors prescription upon hospital discharge

Published:November 15, 2022DOI:https://doi.org/10.1016/j.dld.2022.10.018

      Abstract

      Background

      There is an increasing interest in inappropriate proton pump inhibitors prescription (InPPIp), as defined by the National Institute for Clinical Excellence (NICE) guidelines.

      Aims

      To evaluate the rate, trend over time and factors associated with InPPIp upon discharge from internal medicine departments.

      Methods

      We evaluated patients discharged from internal medicine departments with a PPI prescription in 2014 and 2017 at an academic referral center according to a developed algorithm.

      Results

      A total of 3,982 patients were included (50.8% women, 74% ≥ 65 years). The rate of InPPIp was 44.3% (95% CI 42.8–45.9) for the entire cohort; 68.1% for subjects aged < 65 years and 36.0% for those aged ≥ 65 years (p<0.001); 43.2% in 2014 and 45.6% in 2017 (p = 0.130). In a decision-tree analysis, after the exclusion of 448 patients with gastrointestinal indications, 89.4% (1,580/1,766) of all InPPIp cases were of patients without dual antiplatelet treatment (DAPT) and 8.6% (151/1,766) were of patients younger than 65 years, who were taking aspirin.

      Conclusions

      The rate of InPPIp is high, especially among patients not receiving DAPT and young patients taking aspirin. Time trend analysis showed no improvement over time. Our algorithm may serve as an automated quality measuring tool to reduce InPPIp.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Muheim L.
        • Signorell A.
        • Markun S.
        • et al.
        Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis.
        Therap Adv Gastroenterol. 2021; 14 (1756284821998928. 2021/05/06)https://doi.org/10.1177/1756284821998928
        • Sattayalertyanyong O.
        • Thitilertdecha P.
        • Auesomwang C.
        The inappropriate use of proton pump inhibitors during admission and after discharge: a prospective cross-sectional study.
        Int J Clin Pharm. 2020; 42 (2019/12/23): 174-183https://doi.org/10.1007/s11096-019-00955-8
        • Savarino V.
        • Dulbecco P.
        • de Bortoli N.
        • et al.
        The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal.
        Eur J Intern Med. 2017; 37 (2016/10/28): 19-24https://doi.org/10.1016/j.ejim.2016.10.007
        • Freedberg D.E.
        • Kim L.S.
        • Yang Y.X
        The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association.
        Gastroenterology. 2017; 152 (2017/03/05): 706-715https://doi.org/10.1053/j.gastro.2017.01.031
        • Scarpignato C.
        • Gatta L.
        • Zullo A.
        • et al.
        Effective and safe proton pump inhibitor therapy in acid-related diseases - a position paper addressing benefits and potential harms of acid suppression.
        BMC Med. 2016; 14 (2016/11/09): 179https://doi.org/10.1186/s12916-016-0718-z
      1. Canada C.W. By By PPI, https://choosingwiselycanada.org/perspective/ppi-toolkit/(2019, 2021).

        • Katz P.O.
        • Gerson L.B.
        • Vela M.F.
        Guidelines for the diagnosis and management of gastroesophageal reflux disease.
        Am J Gastroenterol. 2013; 108 (quiz 329. 2013/02/20): 308-328https://doi.org/10.1038/ajg.2012.444
        • Shaheen N.J.
        • Falk G.W.
        • Iyer P.G.
        • et al.
        ACG clinical guideline: diagnosis and management of Barrett's Esophagus.
        Am J Gastroenterol. 2016; 111 (quiz 51. 2015/11/04): 30-50https://doi.org/10.1038/ajg.2015.322
        • Lanza F.L.
        • Chan F.K.
        • Quigley E.M
        Guidelines for prevention of NSAID-related ulcer complications.
        Am J Gastroenterol. 2009; 104 (2009/02/26): 728-738https://doi.org/10.1038/ajg.2009.115
        • Kahrilas P.J.
        • Shaheen N.J.
        • Vaezi M.F.
        American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease.
        Gastroenterology. 2008; 135 (1413.e1391-1395. 2008/09/20): 1392-1413https://doi.org/10.1053/j.gastro.2008.08.044
        • Abraham N.S.
        • Hlatky M.A.
        • Antman E.M.
        • et al.
        ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
        Circulation. 2010; 122 (2010/11/10): 2619-2633https://doi.org/10.1161/CIR.0b013e318202f701
        • Laine L.
        • Nagar A.
        Long-term PPI use: balancing Potential harms and documented benefits.
        Am J Gastroenterol. 2016; 111 (2016/04/27): 913-915https://doi.org/10.1038/ajg.2016.156
      2. Pharmacists CSoH. Six things clinicians and patients should question, https://choosingwiselycanada.org/hospital-pharmacy/(2020).

        • Stasi E.
        • Michielan A.
        • Morreale G.C.
        • et al.
        Five common errors to avoid in clinical practice: the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) Choosing Wisely Campaign.
        Intern Emerg Med. 2019; 14: 301-308
        • Levinson W.
        • Kallewaard M.
        • Bhatia R.S.
        • et al.
        Choosing Wisely': a growing international campaign.
        BMJ Qual Saf. 2015; 24 (2015/01/02): 167-174https://doi.org/10.1136/bmjqs-2014-003821
        • Cook D.S.
        Choosing Wisely Canada recommendations.
        Can Fam Physician. 2016; 62 (2017/07/01): 902
      3. (NICE) TNIfHaCE. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management Clinical guideline [CG184], https://www.nice.org.uk/guidance/cg184 (2014, 04/2020).

        • Spechler S.J.
        • Sharma P.
        • Souza R.F.
        • et al.
        American Gastroenterological Association medical position statement on the management of Barrett's esophagus.
        Gastroenterology. 2011; 140 (2011/03/08): 1084-1091https://doi.org/10.1053/j.gastro.2011.01.030
        • Savarino V.
        • Marabotto E.
        • Zentilin P.
        • et al.
        Proton pump inhibitors: use and misuse in the clinical setting.
        Expert Rev Clin Pharmacol. 2018; 11 (2018/10/09): 1123-1134https://doi.org/10.1080/17512433.2018.1531703
        • Ahrens D.
        • Chenot J.F.
        • Behrens G.
        • et al.
        Appropriateness of treatment recommendations for PPI in hospital discharge letters.
        Eur J Clin Pharmacol. 2010; 66 (2010/08/10): 1265-1271https://doi.org/10.1007/s00228-010-0871-9
        • Ahrens D.
        • Behrens G.
        • Himmel W.
        • et al.
        Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care.
        Int J Clin Pract. 2012; 66 (2012/07/19): 767-773https://doi.org/10.1111/j.1742-1241.2012.02973.x
        • Bulger J.
        • Nickel W.
        • Messler J.
        • et al.
        Choosing wisely in adult hospital medicine: five opportunities for improved healthcare value.
        J Hosp Med. 2013; 8 (2013/08/21): 486-492https://doi.org/10.1002/jhm.2063
        • Lodato F.
        • Poluzzi E.
        • Raschi E.
        • et al.
        Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: attitudes of general practitioners and hospital physicians in Italy.
        Eur J Intern Med. 2016; 30 (2016/03/02): 31-36https://doi.org/10.1016/j.ejim.2016.01.025
        • Barda N.
        • Dagan N.
        • Ben-Shlomo Y.
        • et al.
        Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting.
        N Engl J Med. 2021; (2021/08/26)https://doi.org/10.1056/NEJMoa2110475
        • Naunton M.
        • Peterson G.M.
        • Deeks L.S.
        • et al.
        We have had a gutful: the need for deprescribing proton pump inhibitors.
        J Clin Pharm Ther. 2018; 43 (2017/09/13): 65-72https://doi.org/10.1111/jcpt.12613
        • Haroon M.
        • Yasin F.
        • Gardezi S.K.
        • et al.
        Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study.
        JRSM Short Rep. 2013; 4 (2013/09/17)2042533313497183https://doi.org/10.1177/2042533313497183
        • Scagliarini R.
        • Magnani E.
        • Praticò A.
        • et al.
        Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice.
        Dig Dis Sci. 2005; 50 (2006/01/18): 2307-2311https://doi.org/10.1007/s10620-005-3052-4
        • Batuwitage B.T.
        • Kingham J.G.
        • Morgan N.E.
        • et al.
        Inappropriate prescribing of proton pump inhibitors in primary care.
        Postgrad Med J. 2007; 83 (2007/02/03): 66-68https://doi.org/10.1136/pgmj.2006.051151